Pharming (PHAR) Exchange Rate Effect (2020 - 2026)

Pharming (PHAR) has 6 years of Exchange Rate Effect data on file, last reported at $1.2 million in Q4 2025.

• Quarterly Exchange Rate Effect rose 155.93% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.4 million (up 36.45% YoY) and the FY2025 annual result came in at $7.9 million, up 458.11% from the prior year.
• Exchange Rate Effect improved to $1.2 million in Q4 2025, from -$2.2 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $4.4 million in Q3 2021 to a low of -$11.7 million in Q3 2022.
• A 5-year average of -$1.1 million and a median of -$122500.0 in 2021 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2021 — Exchange Rate Effect slumped 4498.65% — and 2022, when it surged 162.31%.
• Tracing PHAR's Exchange Rate Effect over 5 years: stood at -$650000.0 in 2021, then surged by 162.31% to $405000.0 in 2022, then climbed by 8.4% to $439000.0 in 2023, then sank by 602.96% to -$2.2 million in 2024, then surged by 155.93% to $1.2 million in 2025.
• The last three Exchange Rate Effect figures came in at $1.2 million (Q4 2025), -$2.2 million (Q4 2024), and $439000.0 (Q4 2023), per Business Quant data.